Pen & Strep Suspension for Injection

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: VMD (Veterinary Medicines Directorate)

Ակտիվ բաղադրիչ:

Dihydrostreptomycin Sulphate, Procaine Benzylpenicillin

Հասանելի է:

Norbrook Laboratories Limited

ATC կոդը:

QJ01RA01

INN (Միջազգային անվանումը):

Dihydrostreptomycin Sulphate, Procaine Benzylpenicillin

Դեղագործական ձեւ:

Suspension for injection

Ռեկվիզորի տեսակը:

POM-V - Prescription Only Medicine – Veterinarian

Թերապեւտիկ խումբ:

Cattle, Horses, Pigs, Sheep

Թերապեւտիկ տարածք:

Antimicrobial

Լիազորման կարգավիճակը:

Authorized

Հաստատման ամսաթիվը:

1991-03-12

Ապրանքի հատկությունները

Revised: April 2024
AN: 02550/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Pen & Strep Suspension for Injection.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ACTIVE SUBSTANCE_
Procaine Penicillin
200 mg
Dihydrostreptomycin Sulphate
250 mg
_EXCIPIENTS_
The
product
also
contains
1.5mg
Hydroxybenzoate
Esters
(as
Nipasept
Sodium)
as
antimicrobial
preservative
and
1.25mg
sodium
formaldehyde
sulphoxylate dihydrate as antioxidant.
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for Injection
A white to off-white aqueous suspension for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
Horses
Sheep
Pigs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of systemic infections in cattle, horses, sheep and
pigs
caused
by
or
associated
with
organisms
sensitive
to
penicillin
and/or
streptomycin including:
_Arcanobacterium pyogenes_
_Erysipelothrix rhusiopathiae_
_Klebsiella pneumoniae_
_Listeria_ spp
_Mannheimia haemolytica_
_Pasteurella multocida_
_Staphylococcus_ spp (non-penicillinase producing)
_Streptococcus_ spp
Revised: April 2024
AN: 02550/2023
Page 2 of 6
_Salmonella_ spp
and for the control of secondary bacterial infection with sensitive
organisms in
diseases primarily associated with viral infection.
4.3
CONTRAINDICATIONS
Contraindicated in known cases of hypersensitivity to penicillins.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Use with care in animals known to have kidney disease or defective
renal
function.
Do not exceed the recommended dosage or duration of treatment.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals:
Care
should
be
taken
not
to
exceed
the
recommended
dosage.
Aminoglycosides have a narrower margin of safety than beta lactam
antibiotics.
ii.
Special
precautions
to
be
taken
by
the
person
administering
the
product to the animals:
Care should be taken to avoid accidental self-injection. In the case
of
accidental self-injection, seek medical advice immediate